{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:24:46Z","timestamp":1787102686851,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Independent Innovation Science Fund of PLA General Hospital","award":["22QNFC087"],"award-info":[{"award-number":["22QNFC087"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3605501"],"award-info":[{"award-number":["2023YFC3605501"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3605500"],"award-info":[{"award-number":["2023YFC3605500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05099-x","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:45:47Z","timestamp":1781232347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["iMSC-secreted factors preserve renal capillary networks and ameliorate fibrosis by interrupting the macrophage STING\/CD8+ T cell axis in ischemic kidney disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Mengkun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaBin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueru","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangguo","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"9","key":"5099_CR1","doi-asserted-by":"publisher","first-page":"ITC129","DOI":"10.7326\/ANNALS-25-02684","volume":"178","author":"ME Grams","year":"2025","unstructured":"Grams ME, Melamed ML. Chronic kidney disease. Ann Intern Med. 2025;178(9):ITC129\u201344.","journal-title":"Ann Intern Med"},{"issue":"4S","key":"5099_CR2","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"7","key":"5099_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"5099_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","volume":"9","author":"J Behr","year":"2021","unstructured":"Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, et al. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med. 2021;9(5):476\u201386.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"5099_CR5","doi-asserted-by":"publisher","first-page":"2402249","DOI":"10.1183\/13993003.02249-2024","volume":"65","author":"G Bermudo-Peloche","year":"2025","unstructured":"Bermudo-Peloche G, Del Rio B, Vicens-Zygmunt V, Bordas-Martinez J, Hern\u00e1ndez M, et al. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. Eur Respir J. 2025;65(4):2402249.","journal-title":"Eur Respir J"},{"issue":"1","key":"5099_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40364-024-00641-6","volume":"12","author":"Q Wei","year":"2024","unstructured":"Wei Q, Gan C, Sun M, Xie Y, Liu H, et al. BRD4: an effective target for organ fibrosis. Biomark Res. 2024;12(1):92.","journal-title":"Biomark Res"},{"issue":"8","key":"5099_CR7","doi-asserted-by":"publisher","first-page":"e12472","DOI":"10.1002\/jev2.12472","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Sun L, Li Y, Holmes C. Mesenchymal stromal\/stem cell tissue source and in vitro expansion impact extracellular vesicle protein and miRNA compositions as well as angiogenic and immunomodulatory capacities. J Extracell Vesicles. 2024;13(8):e12472.","journal-title":"J Extracell Vesicles"},{"key":"5099_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s13287-025-04707-6","volume":"16","author":"IS Ali","year":"2025","unstructured":"Ali IS, Abdel-Wahab ND, Nabil A. Stem cells harvested from different sources ameliorate liver fibrosis: comparative study. Stem Cell Res Ther. 2025;16:598.","journal-title":"Stem Cell Res Ther"},{"issue":"28","key":"5099_CR9","doi-asserted-by":"publisher","first-page":"2308975","DOI":"10.1002\/advs.202308975","volume":"11","author":"T Winston","year":"2024","unstructured":"Winston T, Song Y, Shi H, Yang J, Alsudais M, et al. Lineage-specific mesenchymal stromal cells derived from human iPSCs showed distinct patterns in transcriptomic profile and extracellular vesicle production. Adv Sci (Weinh). 2024;11(28):2308975.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5099_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ijms24010881","volume":"24","author":"HR Lee","year":"2023","unstructured":"Lee HR, Kim S, Shin S, Jeong SY, Lee DW, et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs. Int J Mol Sci. 2023;24(1):881.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5099_CR11","doi-asserted-by":"publisher","first-page":"e2936","DOI":"10.1002\/iub.2936","volume":"77","author":"H Ren","year":"2025","unstructured":"Ren H, Wang Y, Chen Y, Ma F, Shi Q, et al. The therapeutic effects of induced pluripotent stem cell-derived mesenchymal stem cells on parkinson\u2019s disease. IUBMB Life. 2025;77(1):e2936.","journal-title":"IUBMB Life"},{"issue":"1","key":"5099_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13287-025-04215-7","volume":"16","author":"MS Lee","year":"2025","unstructured":"Lee MS, Lin EC, Sivapatham A, Leiferman EM, Jiao H, et al. Autologous iPSC- and MSC-derived chondrocyte implants for cartilage repair in a miniature pig model. Stem Cell Res Ther. 2025;16(1):86.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"5099_CR13","doi-asserted-by":"publisher","first-page":"e10743","DOI":"10.1002\/btm2.10743","volume":"10","author":"EH Powsner","year":"2025","unstructured":"Powsner EH, Kronstadt SM, Nikolov K, Aranda A, Jay SM. Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness. Bioeng Transl Med. 2025;10(3):e10743.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"5099_CR14","doi-asserted-by":"publisher","first-page":"e0606242024","DOI":"10.1523\/JNEUROSCI.0606-24.2024","volume":"45","author":"K Kawatani","year":"2025","unstructured":"Kawatani K, Omana Suarez G, Perkerson RB 3rd, Parent EE, Nambara T, et al. Human iPSC-derived MSCs induce neurotrophic effects and improve metabolic activity in acute neuronal injury models. J Neurosci. 2025;45(1):e0606242024.","journal-title":"J Neurosci"},{"issue":"1","key":"5099_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12951-024-02410-x","volume":"22","author":"SY Jeong","year":"2024","unstructured":"Jeong SY, Park BW, Kim J, Lee S, You H, et al. Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct. J Nanobiotechnol. 2024;22(1):149.","journal-title":"J Nanobiotechnol"},{"key":"5099_CR16","unstructured":"Kim J, Lee SK, Jeong SY, You H, Han SD et al. Multifaceted action of stem cell-derived extracellular vesicles for nonalcoholic steatohepatitis. J Control Release. 2023: S0168-3659(23)706-X."},{"issue":"1","key":"5099_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13287-024-03847-5","volume":"15","author":"K Gupta","year":"2024","unstructured":"Gupta K, Perkerson RB 3rd, Parsons TM, Angom R, Amerna D, et al. Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage. Stem Cell Res Ther. 2024;15(1):230.","journal-title":"Stem Cell Res Ther"},{"issue":"26","key":"5099_CR18","doi-asserted-by":"publisher","first-page":"e2300879","DOI":"10.1002\/adhm.202300879","volume":"12","author":"D Levy","year":"2023","unstructured":"Levy D, Abadchi SN, Shababi N, Ravari MR, Pirolli NH, et al. Induced pluripotent stem cell-derived extracellular vesicles promote wound repair in a diabetic mouse model via an anti-inflammatory immunomodulatory mechanism. Adv Healthc Mater. 2023;12(26):e2300879.","journal-title":"Adv Healthc Mater"},{"key":"5099_CR19","doi-asserted-by":"crossref","unstructured":"Hynes K, Bright R, Marino V, Ng J, Verma PJ et al. Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease. Stem Cells Int. 2018, 2018: 2601945.","DOI":"10.1155\/2018\/2601945"},{"key":"5099_CR20","doi-asserted-by":"crossref","unstructured":"Li L, Liao J, Zhang Y, Yao Z, Huang J et al. Single Cell and Spatial Transcriptomics Define a Proinflammatory and Profibrotic Niche After Kidney Injury. Adv Sci (Weinh). 2025: e03691.","DOI":"10.1002\/advs.202503691"},{"issue":"12","key":"5099_CR21","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/ATVBAHA.123.318974","volume":"43","author":"J Tan","year":"2023","unstructured":"Tan J, Liang Y, Yang Z, He Q, Tong J, et al. Single-cell transcriptomics reveals crucial cell subsets and functional heterogeneity associated with carotid atherosclerosis and cerebrovascular events. Arterioscler Thromb Vasc Biol. 2023;43(12):2312\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"5099_CR22","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1097\/TP.0000000000000237","volume":"98","author":"A Lau","year":"2014","unstructured":"Lau A, Khan K, Pavlosky A, Yin Z, Huang X, et al. Serine protease inhibitor-6 inhibits granzyme B-mediated injury of renal tubular cells and promotes renal allograft survival. Transplantation. 2014;98(4):2025\u201311.","journal-title":"Transplantation"},{"issue":"9","key":"5099_CR23","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/cells11091510","volume":"11","author":"A Linke","year":"2022","unstructured":"Linke A, Cicek H, M\u00fcller A, Meyer-Schwesinger C, Melderis S, et al. Antigen cross-presentation by murine proximal tubular epithelial cells induces cytotoxic and inflammatory CD8\u2009+\u2009T cells. Cells. 2022;11(9):1510.","journal-title":"Cells"},{"issue":"4","key":"5099_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/ki.1993.302","volume":"44","author":"C Diaz-Gallo","year":"1993","unstructured":"Diaz-Gallo C, Kelley VR. Self-regulation of autoreactive kidney-infiltrating T cells in MRL-lpr nephritis. Kidney Int. 1993;44(4):692\u20139.","journal-title":"Kidney Int"},{"key":"5099_CR25","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang Y, Liu H, Tang K, Zhang C et al. IL-15 induced bystander activation of CD8\u2009+\u2009T cells may mediate endothelium injury through NKG2D in Hantaan virus infection. Front Cell Infect Microbiol. 2022, 12[2025-11-09].","DOI":"10.3389\/fcimb.2022.1084841"},{"issue":"1","key":"5099_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12964-025-02444-0","volume":"23","author":"X Su","year":"2025","unstructured":"Su X, Huang R, Kang D, Wang J, Li L, et al. Blocking CCR1\u2009+\u2009macrophages overcomes resistance to immune checkpoint inhibitors in melanoma. Cell Commun Signal. 2025;23(1):475.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5099_CR27","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1038\/s41467-025-64023-8","volume":"16","author":"R Li","year":"2025","unstructured":"Li R, Kang Y, Ran N, Niu G, Fan Y, et al. Micro-nano microbial fuel cell-driven bioelectrochemical tumor therapy. Nat Commun. 2025;16(1):8989.","journal-title":"Nat Commun"},{"key":"5099_CR28","unstructured":"Ma Y, Su X, Zeng T, Zhou C, Yang G et al. CCL5hi Macrophages Interact with CD8\u2009+\u2009T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma. Adv Sci (Weinh). 2025: e09187."},{"issue":"9","key":"5099_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5099_CR30","doi-asserted-by":"publisher","first-page":"156785","DOI":"10.1016\/j.phymed.2025.156785","volume":"142","author":"Y Gao","year":"2025","unstructured":"Gao Y, Wei T, Mu L, Liu C, Zeng Y, et al. Targeting STING and protecting mitochondrial function with nephropathy \u2161 decoction to alleviate renal fibrosis. Phytomedicine. 2025;142:156785.","journal-title":"Phytomedicine"},{"issue":"1","key":"5099_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/path.6414","volume":"266","author":"Z Ren","year":"2025","unstructured":"Ren Z, Shao F, Chen S, Sun Y, Ding Z, et al. Contribution of alterations in peritubular capillary density and microcirculation to the progression of tubular injury and kidney fibrosis. J Pathol. 2025;266(1):95\u2013108.","journal-title":"J Pathol"},{"issue":"7","key":"5099_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41581-025-00958-x","volume":"21","author":"XM Meng","year":"2025","unstructured":"Meng XM, Wang L, Nikolic-Paterson DJ, Lan HY. Innate immune cells in acute and chronic kidney disease. Nat Rev Nephrol. 2025;21(7):464\u201382.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"5099_CR33","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/s41423-021-00763-z","volume":"18","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Luo Z, Liao C, Cao R, Hussain Z, et al. MHC class II in renal tubules plays an essential role in renal fibrosis. Cell Mol Immunol. 2021;18(11):2530\u201340.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"5099_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10456-023-09883-8","volume":"27","author":"Steegh","year":"2024","unstructured":"Steegh FMEG, Keijbeck AA, de Hoogt PA, Rademakers T, Houben AJHM, et al. Capillary rarefaction: a missing link in renal and cardiovascular disease? Angiogenesis. 2024;27(1):23\u201335.","journal-title":"Angiogenesis"},{"issue":"13","key":"5099_CR35","doi-asserted-by":"publisher","first-page":"e2303276","DOI":"10.1002\/adhm.202303276","volume":"13","author":"L Xu","year":"2024","unstructured":"Xu L, Xing Z, Yuan J, Han Y, Jiang Z, et al. Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL-33\/ST2 to Alleviate Renal Ischemia-Reperfusion Injury. Adv Healthc Mater. 2024;13(13):e2303276.","journal-title":"Adv Healthc Mater"},{"key":"5099_CR36","doi-asserted-by":"crossref","unstructured":"Jia H, Yue G, Li P, Peng R, Jin R et al. Neutrophil extracellular traps license macrophage production of chemokines to facilitate CD8\u2009+\u2009T cell infiltration in obstruction-induced renal fibrosis. Protein Cell. 2025, pwaf020.","DOI":"10.1093\/procel\/pwaf020"},{"issue":"7","key":"5099_CR37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/biom11070990","volume":"11","author":"M Gao","year":"2021","unstructured":"Gao M, Wang J, Zang J, An Y, Dong Y. The mechanism of CD8\u2009+\u2009T cells for reducing myofibroblasts accumulation during renal fibrosis. Biomolecules. 2021;11(7):990.","journal-title":"Biomolecules"},{"issue":"4","key":"5099_CR38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.4049\/jimmunol.1501232","volume":"196","author":"Y Dong","year":"2016","unstructured":"Dong Y, Yang M, Zhang J, Peng X, Cheng J, et al. Depletion of CD8\u2009+\u2009T Cells Exacerbates CD4\u207a T Cell-Induced Monocyte-to-Fibroblast Transition in Renal Fibrosis. J Immunol. 2016;196(4):1874\u201381.","journal-title":"J Immunol"},{"issue":"8","key":"5099_CR39","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.7150\/ijbs.96812","volume":"20","author":"W Jiang","year":"2024","unstructured":"Jiang W, Tang TT, Zhang YL, Li ZL, Wen Y, et al. CD8 T cells induce the peritubular capillary rarefaction during AKI to CKD transition. Int J Biol Sci. 2024;20(8):2980\u201393.","journal-title":"Int J Biol Sci"},{"issue":"19\u201320","key":"5099_CR40","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1089\/ten.tea.2010.0716","volume":"17","author":"SE Hanson","year":"2011","unstructured":"Hanson SE, King SN, Kim J, Chen X, Thibeault SL, et al. The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A. 2011;17(19\u201320):2463\u201371.","journal-title":"Tissue Eng Part A"},{"key":"5099_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s13287-020-02035-5","volume":"11","author":"C Giannasi","year":"2020","unstructured":"Giannasi C, Niada S, Magagnotti C, Ragni E, Andolfo A, et al. Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles. Stem Cell Res Ther. 2020;11:521.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5099_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-025-03555-9","volume":"44","author":"Z Li","year":"2025","unstructured":"Li Z, Zheng W, Liu Y, Cao R, Wei J, et al. Bridging innate and adaptive tumor immunity: cGAS-STING pathway activation to potentiate immune checkpoint blockade. J Exp Clin Cancer Res. 2025;44(1):303.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"5099_CR43","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/s41423-020-0456-1","volume":"18","author":"C Fang","year":"2021","unstructured":"Fang C, Mo F, Liu L, Du J, Luo M, et al. Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine. Cell Mol Immunol. 2021;18(9):2211\u201323.","journal-title":"Cell Mol Immunol"},{"key":"5099_CR44","doi-asserted-by":"publisher","first-page":"110777","DOI":"10.1016\/j.vetmic.2025.110777","volume":"311","author":"H Li","year":"2025","unstructured":"Li H, Mo J, Li S, Guo R, Fang Y, et al. RSAD2 inhibits senecavirus a replication by promoting type I interferons induction downstream of cGAS-STING and NF-\u03baB signaling pathway. Vet Microbiol. 2025;311:110777.","journal-title":"Vet Microbiol"},{"issue":"5","key":"5099_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122(5):669\u201382.","journal-title":"Cell"},{"issue":"815","key":"5099_CR46","doi-asserted-by":"publisher","first-page":"eabq1173","DOI":"10.1126\/scisignal.abq1173","volume":"16","author":"Z Korwek","year":"2023","unstructured":"Korwek Z, Czerkies M, Jaruszewicz-B\u0142o\u0144ska J, Prus W, Kosiuk I, et al. Nonself RNA rewires IFN-\u03b2 signaling: a mathematical model of the innate immune response. Sci Signal. 2023;16(815):eabq1173.","journal-title":"Sci Signal"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05099-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:39:47Z","timestamp":1787099987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5099"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05099-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal Ethics declaration: (1) Title of the approved project: Comparison of three animal models of transformation from AKI to CKD. (2) Ethics committee (institutional): Ethics Committee of the Animal Care and Use Committee of Beijing Institute of Radiation Medicine. (3) Ethics approval code: IACUC-DWZX-2024-P647. (4) Animal experiments were approved on August 12, 2024, and performed in compliance with the ARRIVE guidelines. Cell Ethics declaration: (1)We purchased iMSCs from Nuwacell Ltd. (Hefei, China). The company has provided formal documentation confirming that: The original human somatic cells (from which the iMSCs were reprogrammed) were collected under protocols reviewed and approved by an accredited Ethics Committee. All donors gave written informed consent for research use of their biological samples. Ethics approval code: ASSCR-YXLL-2019-03. (2)The HK-2 cell line (RRID: CVCL_0302) used in this study is a commercially available, immortalized cell line. This cell line was originally established and characterized by Ryan et al. The cells we used were purchased from [Procell Life Science & Technology Co.,Ltd.], which guarantees that its products are sourced in compliance with ethical standards. In accordance with our institution\u2019s policy, no additional ethical approval is required for the use of such established, de-identified commercial cell lines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"286"}}